- Phone
-
Address
Room 312, Building J, Haitai Green Industry Base, No. 6 Haitai Development Road, Huayuan Industrial Zone, Binhai New Area, Tianjin
Tianjin Aser Biotechnology Co., Ltd
Room 312, Building J, Haitai Green Industry Base, No. 6 Haitai Development Road, Huayuan Industrial Zone, Binhai New Area, Tianjin
Rapid detection kit for myasthenia gravis ELISA ChRAb
Rapid detection kit for myasthenia gravis ELISA ChRAb
This product has been approved by the European UnionCEcertification
1. Expected use:
RSR AChR Ab Fast ELISAThe reagent kit is used for quantitative detection of acetylcholine receptor autoantibodies in human serum(AChR Ab)It is a diagnosis of myasthenia gravis(Myasthenia Gravis)Important basis.For scientific research purposes only.
2. Detection significance:
Myasthenia gravis is caused by the patient's bodyAChR AbActing on the nerves-Acetylcholine receptors at the muscle junction, leading to autoimmune diseases caused by transmission dysfunction, detectionAChR AbHelps with the diagnosis and treatment of the disease.
3. Characteristics of the reagent kit:
The characteristic of this kit is to use a highly purified mixture of adult and fetal acetylcholine receptors as antigens, which are applied in the patient's bodyAChRAbThe principle of competing for antigen surface binding sites with three types of monoclonal antibodies has become the first international detectionAChR AbEnzyme immunoassay kit. Its sensitivity and specificity are the same as those of our companyAChR AbThe exemption kit is similar and continues to be used in the UK National Quality Assessment Service(NEQAS)Achieve excellent results. Its testing results are reliable, suitable for use in clinical laboratories at all levels of hospitals, and can be used in conjunction with automated testing systems.
sensitivity92%Using this reagent kit, serum samples from 48 patients diagnosed with myasthenia gravis were tested, of which 44 cases (92%) were positive for AChRAb.
Specificity 100%: This kit was used to detect the serum of 50 healthy volunteers, and the AChRAb test results of 50 samples (100%) were negative.
4. Sample requirements:
per well100Microliters of human serum should be used, avoiding the use of lipid blood, hemolysis, and plasma samples.
5. Component traits:
96Orifice plates, liquids, and freeze-dried powders.